Statement Of Comprehensive Income [Abstract]

Innate Pharma - Filing #2821023

Concept	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31	2019-01-01 to 2019-12-31
Statement of comprehensive income [abstract]
Profit (loss)	—	—	63 984 EUR	63 984 EUR	—	20 759 EUR	20 759 EUR
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) on remeasurements of defined benefit plans	—	200,000 EUR	200,000 EUR	—	622,000 EUR	—	622,000 EUR
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	805,000 EUR	1 027 EUR	222,000 EUR	—	5,000 EUR	—	5,000 EUR
Financial assets measured at fair value through other comprehensive income [abstract]
Other comprehensive income, net of tax, financial assets measured at fair value through other comprehensive income	—	—	— EUR	—	—	—	— EUR
Other comprehensive income	—	—	22,000 EUR	—	—	—	627,000 EUR
Comprehensive income	805,000 EUR	827,000 EUR	63 962 EUR	63 984 EUR	627,000 EUR	20 759 EUR	20 132 EUR